HOME >> BIOLOGY >> NEWS
Fatal Frog Fungus Found In The United States

A fatal skin fungus, which devastated frogs in parts of Australia and Panama, has turned up in a dying, wild frog in Arizona, according to a University of Arizona researcher.

The discovery of chytrid ("KIT-trid") infection in this lowland leopard frog raises the possibility that the disease has played a role in mysterious amphibian die-offs in the United States, reports the July 4 Science News magazine.

Pathologists had already noted occasional chytrid outbreaks in U.S. zoos. Until now, the few wild amphibians found with the fungus -- in Maryland and Illinois -- did not seem ill. The Arizona frog, however, had a life-threatening illness, reports herpetologist Philip C. Rosen, at the University of Arizona in Tucson. He collected the frog in a relatively undisturbed spot near Cienega Creek.

Pathologist Donald K. Nichols of the National Zoological Park in Washington, D.C. diagnosed chytrid infection. He found the same disease in another species Rosen collected, a fatally ill Chiricahua leopard frog from an outdoor enclosure at San Bernadino National Wildlife Refuge in Arizona.

Both species have suffered die-offs during the last decade, Rosen says. The Chiricahua leopard frog has not bounced back well and has been proposed as a candidate for listing as an endangered species. What role the fungus might have played in these die-offs is far from clear, Rosen says, but "we're taking it very seriously."

The chytrid fungus first made headlines two weeks ago when an international team of scientists fingered it as the culprit in die-offs of 19 species of amphibians in apparently pristine streams in Central America and Australia. Details will appear in the July 21 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES.

The Panamanian outbreak caught the attention of Karen Lips of Southern Illinois University in Carbondale during a visit to Panama in 1997. Forest scavengers are so efficient that herpetologists typically find few dead animals lying uneaten d
'"/>

Contact: Susan Milius
smilius@sciserv.org
202-872-5124
Science News
2-Jul-1998


Page: 1 2

Related biology news :

1. Fatal thrombotic disease in designer mice lacking vascular thrombomodulin
2. Fatal attraction: Satellites to determine sea lions deaths
3. New Evidence On How Prions Turn Fatal
4. UF Researchers: Gene Therapy Replaces Critical Protein In Animal Model Of Often-Fatal Lung-Liver Disease
5. Scientists Find New Clues About Fatal Childhood Disease, Ataxia Telangiectasia
6. Florida Researchers Discover Gene For Fatal Childhood Disease
7. Fungus-enhanced plants popular with grasshoppers
8. Ant-Fungus Relationship May Provide New Clues About Antibiotics
9. How Can You Tell Whether Corn Is Fungus-Ridden?
10. Household Fungus Contributes To "Sick Building Syndrome"
11. USGS Finds Fungus To Be A Cause Of Fish Lesions In Chesapeake

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fatal Frog Fungus Found The United States

(Date:5/21/2013)... types become most deadly when they metastasize and spread ... stage, it becomes very difficult for doctors to locate ... researchers at the University of Missouri have found a ... cells wherever they may be in the body. Michael ... College of Veterinary Medicine, says being able to target ...
(Date:5/21/2013)... available in pharmacies and health stores, phosphatidylserine is ... and soy. Proven to improve cognition and slow ... people experiencing memory impairment. Now a team headed ... of Tel Aviv University,s Department of Human ... supplement improves the functioning of genes involved in ...
(Date:5/21/2013)... Try staying fit in space, where living quarters are ... That,s the challenge a group of Michigan State University ... grant from NASA. Their goal is to keep astronauts ... could give astronauts the best exercise regimen there is, ... it, it isn,t going to help," said project leader ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Common food supplement fights degenerative brain disorders 2Fueling fitness on the final frontier 2
(Date:5/21/2013)... 21, 2013 According to a ... http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, Reagents, ... Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market ... is expected to grow at a CAGR of 10.1% ... of USD 4.7 billion in 2018. Browse ...
(Date:5/21/2013)... Miami, FL (PRWEB) May 21, 2013 ... and breakouts as contributor to acne. Recently physicians from ... effects of mental stress on the skin, and suggested ... to help reduce the chemicals produced from stress that ... aside from the negative feelings acne brings about, stress ...
(Date:5/21/2013)... May 21, 2013  MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM.  The presentation will describe the ...
(Date:5/21/2013)... , May 21, 2013  Personal Genome ... use its proprietary methodologies and expertise in genomic ... kinase targets in collaboration with Blueprint Medicines.  PGDx ... at identifying genomic alterations in tumors, and Blueprint ... kinase inhibitors for a genetically defined patient population. ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3
Cached News: